CA2128205C - Methotrexate derivatives - Google Patents

Methotrexate derivatives Download PDF

Info

Publication number
CA2128205C
CA2128205C CA002128205A CA2128205A CA2128205C CA 2128205 C CA2128205 C CA 2128205C CA 002128205 A CA002128205 A CA 002128205A CA 2128205 A CA2128205 A CA 2128205A CA 2128205 C CA2128205 C CA 2128205C
Authority
CA
Canada
Prior art keywords
general formula
compound
carbon atoms
lower alkyl
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002128205A
Other languages
English (en)
French (fr)
Other versions
CA2128205A1 (en
Inventor
Hiroharu Matsuoka
Hiroshi Suzuki
Nobuaki Kato
Keiichiro Tsuji
Toshio Kuroki
Nobuaki Maruyama
Kazuya Nakagomi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of CA2128205A1 publication Critical patent/CA2128205A1/en
Application granted granted Critical
Publication of CA2128205C publication Critical patent/CA2128205C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA002128205A 1992-01-27 1993-01-27 Methotrexate derivatives Expired - Fee Related CA2128205C (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP53051/1992 1992-01-27
JP5305192 1992-01-27
JP75106/1992 1992-02-13
JP7510692 1992-02-13
JP10832092 1992-03-16
JP108320/1992 1992-03-16
JP115126/1992 1992-03-24
JP11512692 1992-03-24
PCT/JP1993/000096 WO1993015077A1 (fr) 1992-01-27 1993-01-27 Derive de methotrexate

Publications (2)

Publication Number Publication Date
CA2128205A1 CA2128205A1 (en) 1993-08-05
CA2128205C true CA2128205C (en) 2004-03-30

Family

ID=27462860

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002128205A Expired - Fee Related CA2128205C (en) 1992-01-27 1993-01-27 Methotrexate derivatives

Country Status (10)

Country Link
US (2) US6559149B1 (enExample)
EP (1) EP0632038B1 (enExample)
KR (1) KR100248324B1 (enExample)
AT (1) ATE204576T1 (enExample)
AU (1) AU3367693A (enExample)
CA (1) CA2128205C (enExample)
DE (1) DE69330639T2 (enExample)
ES (1) ES2161713T3 (enExample)
TW (1) TW223637B (enExample)
WO (1) WO1993015077A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69330639T2 (de) * 1992-01-27 2002-07-04 Chugai Seiyaku K.K., Tokio/Tokyo Methotrexat-derivate
CA2152485A1 (en) * 1992-12-25 1994-07-07 Nobuhiro Ohi Methotrexate derivative
KR100400509B1 (ko) * 1995-03-27 2004-04-03 쥬가이 세이야쿠 가부시키가이샤 메토트렉세이트유도체를함유하는약제
US7276506B2 (en) * 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
CA2408913A1 (en) * 2000-05-16 2001-11-22 Takeda Chemical Industries, Ltd. Melanin-concentrating hormone antagonist
US20070032477A1 (en) * 2003-10-17 2007-02-08 Waer Mark J A Pteridine derivatives useful for making pharmaceutical compositions
US20060039985A1 (en) * 2004-04-27 2006-02-23 Bennett David B Methotrexate compositions
US7601834B2 (en) * 2005-02-22 2009-10-13 Savvipharm Inc Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives
US20070123478A1 (en) 2005-11-28 2007-05-31 Rowe Vernon D Compositions useful for reducing nephrotoxicity and methods of use thereof
WO2007098089A2 (en) * 2006-02-17 2007-08-30 Novacea, Inc. Treatment of hyperproliferative diseases with methotrexate n-oxide and analogs
WO2008009078A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
WO2008009079A2 (en) * 2006-07-20 2008-01-24 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
CN101646670A (zh) 2007-04-11 2010-02-10 默克阿泼洛发股份公司 18f-标记的叶酸酯
EP3173063B1 (en) 2008-11-19 2019-12-25 Pola Chemical Industries Inc. Anti-wrinkle agents
SMT201800023T1 (it) 2015-03-04 2018-03-08 Gilead Sciences Inc Composti 4,6-diamminopirido[3,2-d]pirimidinici modulanti i recettori di tipo toll
ES2826748T3 (es) 2016-09-02 2021-05-19 Gilead Sciences Inc Derivados de 4,6-diamino-pirido[3,2-d]pirimidina como moduladores de receptores de tipo Toll
PT3507276T (pt) 2016-09-02 2022-01-11 Gilead Sciences Inc Compostos moduladores do recetor de tipo toll
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751516B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI879779B (zh) 2019-06-28 2025-04-11 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI812775L (fi) * 1980-09-12 1982-03-13 Farmos Oy Foerfarande foer framstaellning av n-/4-/(2,4-diamino-6-pteridinyl)-metyl/metylamino/benzoyl/glutaminsyra och derivat daerav
US4490529A (en) * 1983-09-06 1984-12-25 Dana-Farber Cancer Institute, Inc. Cysteic acid and homocysteic acid analogues of methotrexate and aminopterin
AU8333291A (en) * 1990-08-14 1992-03-17 Chugai Seiyaku Kabushiki Kaisha Novel methotrexate derivative
JP3124592B2 (ja) * 1990-08-14 2001-01-15 中外製薬株式会社 新規メトトレキセート誘導体
DE69330639T2 (de) * 1992-01-27 2002-07-04 Chugai Seiyaku K.K., Tokio/Tokyo Methotrexat-derivate
JP3207285B2 (ja) * 1992-01-27 2001-09-10 中外製薬株式会社 新規メトトレキセート誘導体
JP3274532B2 (ja) * 1992-03-24 2002-04-15 中外製薬株式会社 抗リウマチ剤

Also Published As

Publication number Publication date
CA2128205A1 (en) 1993-08-05
US6559149B1 (en) 2003-05-06
TW223637B (enExample) 1994-05-11
DE69330639D1 (de) 2001-09-27
US20030171376A1 (en) 2003-09-11
EP0632038B1 (en) 2001-08-22
ES2161713T3 (es) 2001-12-16
EP0632038A1 (en) 1995-01-04
ATE204576T1 (de) 2001-09-15
KR100248324B1 (ko) 2000-04-01
EP0632038A4 (en) 1995-02-22
DE69330639T2 (de) 2002-07-04
AU3367693A (en) 1993-09-01
WO1993015077A1 (fr) 1993-08-05

Similar Documents

Publication Publication Date Title
CA2128205C (en) Methotrexate derivatives
AU592271B2 (en) Anti-cancer quinazoline derivatives
EP0031237A1 (en) Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
RU2266280C2 (ru) Замещенные производные n-бензилиндол-3-ил-глиоксиловой кислоты, обладающие противоопухолевым действием (варианты), их кислотно-аддитивные соли (варианты), фармацевтический препарат, фармацевтическая форма
DK168005B1 (da) N-acyleret diamidderivat af sure aminosyrer og fremgangsmaade til fremstilling af samme samt et antiulcermiddel indeholdende et saadant derivat
US5128345A (en) Carcinostatic composition comprising indolquinolines
US5703089A (en) Dihydrodibenzisoquinolinediones
KR20010013158A (ko) 세포 증식 억제제로서의 시아노구아니딘
Jaycox et al. Potential DNA bis‐intercalating agents: Synthesis and antitumor activity of novel, conformationally restricted bis (9‐aminoacridines)
US4992444A (en) Antifolate agents
US20070105784A1 (en) Substituted quinolines for the treatment of cancer
JP3207285B2 (ja) 新規メトトレキセート誘導体
HU184793B (en) Process for preparing new 7-/4-hydroxy-3-pyrimidinyl/-ureido/-acetamido-3-methyl-cef-3-em-4-carboxylic acid derivatives
US4892939A (en) Oligopeptidyl-5-fluorouridine compounds and process for preparing the same
JP3274532B2 (ja) 抗リウマチ剤
Rosowsky et al. Synthesis and biological activity of the 2-desamino and 2-desamino-2-methyl analogs of aminopterin and methotrexate
JPH08231514A (ja) フェニルベンズイミダゾール誘導体
JPH05194517A (ja) ６−メルカプトプリン誘導体及びその製法
US2577039A (en) Substituted pteridines and method of preparing the same
JP3145533B2 (ja) 新規メトトレキセート誘導体
CN117247374A (zh) 一种bcl-xl抑制剂及其制药用途
JPS61225186A (ja) ５−オクソ−ピリド〔４，３−ｄ〕ピリミジン誘導体、その製造方法および用途
JPS60115584A (ja) メトトレキセ−ト及びアミノプテリンの連鎖延長類似体
JPS6248659A (ja) フエニレン基を有するスパガリン関連ニトリル化合物及びその製造法
JPH0859588A (ja) Ｄ−β−リジルメタンジアミン誘導体、およびそれらの製法

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed